AI team at Insilico gets some major league backing from China as Alex Zhavoronkov builds global network
Some of Asia’s top biotech investors are backing Alex Zhavoronkov’s AI shop at Insilico Medicine.
It’s a long way from a megaround, falling into an unspecified slot in the $5 million to $10 million range, but Zhavoronkov has allied himself with some of the most interesting people in drug development. And he’s using this new money to expand his global network of AI experts as he immediately begins to go after a new raise to back a bigger game plan.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
